SKYSTAR BIO-PHARMACEUTICAL CO Finite-Lived Intangible Assets, Net
SKYSTAR BIO-PHARMACEUTICAL CO had Finite-Lived Intangible Assets, Net of $5.01 million as of 2013-12-31, per its 10-Q filed 2014-11-14.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Intangible Asset, Excluding Goodwill, after Accumulated Amortization › Intangible Asset, Finite-Lived, after Accumulated Amortization
us-gaap:FiniteLivedIntangibleAssetsNet · last filed 2014-11-14
- 2013-12-31: Finite-Lived Intangible Assets, Net $5.01M; Finite-Lived Intangible Assets, Net as first filed $5.24M.
- 2012-12-31: Finite-Lived Intangible Assets, Net $5.28M; Finite-Lived Intangible Assets, Net as first filed $5.32M.
- 2012-06-30: Finite-Lived Intangible Assets, Net $5.51M.
- 2011-12-31: Finite-Lived Intangible Assets, Net $5.41M.
| Period end | Finite-Lived Intangible Assets, Net | Finite-Lived Intangible Assets, Net as first filed |
|---|---|---|
| 2013-12-31 | $5.01M 10-Q · filed 2014-11-14 | $5.24M 10-K · filed 2014-03-31 |
| 2012-12-31 | $5.28M 10-Q · filed 2013-11-14 | $5.32M 10-K · filed 2013-04-01 |
| 2012-06-30 | $5.51M 10-Q/A · filed 2012-09-13 | |
| 2011-12-31 | $5.41M 10-Q · filed 2012-11-14 |